Stomach Cancer Market Size, Segments, and Trends by 2030
Stomach Cancer Market: Strategic Insights
Stomach Cancer Market
-
CAGR (2022 - 2030)14.8% -
Market Size 2022
US$ 3,575.04 Million -
Market Size 2030
US$ 10,751.42 Million
Market Dynamics
GROWTH DRIVERS
- Increase in stomach cancer incidence
- Growing focus on early diagnosis and personalized treatment
FUTURE TRENDS
- Advancements in immunotherapy for stomach cancer
- Increase in combination therapies for gastric cancer treatment
OPPORTUNITIES
- Expansion in cancer therapeutics market
- Increase in global healthcare expenditure on cancer treatments
Key Players
- Bristol Myers Squibb Company
- Novartis AG
- Merck Co Inc
- Eli Lilly and Company
- Biocon
- Teva Pharmaceutical Industries Ltd
- Celltrion Healthcare Co Ltd
- Samsung Bioepis
- Pfizer Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Adenocarcinomas
- Gastrointestinal Stromal Tumors
- Neuroendocrine Tumors
- Lymphoma
Treatment
- Targeted and Immunotherapy Drugs
- Chemotherapy and Combination Drugs
Route of Administration
- Oral
- Parenteral
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies